ElberSCamachoMD

PubMed

• 3 citations
  An unusual case of primary acinar cell carcinoma of the liver and its treatment
  Sharanpreet Kaur, Devin Morris, Grant Ho, Joline Abrahams, Elber Camacho> ;Journal of Gastrointestinal Oncology. 2019 Sep 17
• 4 citations
  Evaluation of factors contributing to the response to fosaprepitant in a heterogeneous, moderately emetogenic chemotherapy population: an exploratory analysis of a ran...
  Cindy Weinstein, Karin Jordan, Stuart A. Green, Elber Camacho, S. Khanani, Elizabeth Beckford-Brathwaite, Annpey Pong, Stephen J. Noga, Bernardo Leon Rapoport> ;Supportive Care in Cancer. 2018 May 28
• 26 citations
  Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethason...
  William I. Bensinger, Sundar Jagannath, Robert Vescio, Elber Camacho, Jeffrey L. Wolf, David Irwin, Gerardo Capo, Marti McKinley, Phyllis Potts, David H. Vesole, Amita...> ;British Journal of Haematology. 2010 Feb 1
• 35 citations
  Extended follow‐up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma
  Sundar Jagannath, Brian G.M. Durie, Jeffrey L. Wolf, Elber Camacho, David Irwin, Jose Lutzky, Marti McKinley, Phyllis Potts, Afshin Eli Gabayan, Amitabha Mazumder, Joh...> ;British Journal of Haematology. 2009 Sep 1
• 258 citations
  Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study
  Jonathan W. Friedberg, Philip Cohen, Ling Chen, K. Sue Robinson, Andres Forero-Torres, Ann S. La Casce, Luis Fayad, Alberto Bessudo, Elber S. Camacho, Michael E. Willi...> ;Journal of Clinical Oncology. 2008 Jan 10
• 305 citations
  Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma.
  Sundar Jagannath, Brian G.M. Durie, Jeffrey L. Wolf, Elber Camacho, David Irwin, Jose Lutzky, Marti McKinley, Eli Gabayan, Amitabha Mazumder, David P. Schenkein, John ...> ;British Journal of Haematology. 2005 Jun 1
• First-line therapy with bortezomib (formerly PS-341) in patients with multiple myeloma (MM).
  Jagannath S, Durie B, Wolf J, Camacho E, Irwin D, Lutzky J, McKinley M, Gabayan E, Crowley J, Schenkein DP> ;J. Clin. Oncol.. 2004-07-15
• 8 citations
  Docetaxel and carboplatin as first-line therapy in advanced non-small cell lung carcinoma: a phase II study.
  Mohammad Jahanzeb, Greg Sarna, Robert Hirsch, Peter Radice, Alan J. Koletsky, Manuel Martinez, Elena Kruglyak, Edward M. Wolin, Elber Camacho, L. Kronish, Susannah Motl> ;Anticancer Research. 2004 Mar 1
• 53 citations
  Adjuvant methotrexate escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas--a prospective, randomized study.
  Robert E. Rentschler, David W. Wilbur, George H. Petti, George D. Chonkich, Dennis A. Hilliard, Elber S. Camacho, Ric B. Thorpe> ;Journal of Clinical Oncology. 1987 Feb 1
• 7 citations
  Tamoxifen response following no response to orchiectomy in metastatic male breast cancer: a case report.
  Dennis A. Hiluard, David W. Wilbur, Elber S. Camacho> ;Journal of Surgical Oncology. 1984 Jan 1
• 9 citations
  DNCB reactivity and prognosis in 419 patients with malignant melanoma
  Elber S. Camacho, Carl M. Pinsky, David W. Braun, Robert B. Golbey, Joseph G. Fortner, Harold J. Wanebo, Herbert F. Oettgen> ;Cancer. 1981 May 15
• Join now to see all